Martinez HR, Rodriguez-Gonzalez IC, Escamilla-Garza JM, Figueroa-Sanchez JA, Garcia-Aleman AC, Hinojosa-Gonzalez DE. Balo's Concentric Sclerosis with monophasic course: A report of 2 cases.
Ann Med Surg (Lond) 2021;
68:102602. [PMID:
34401123 PMCID:
PMC8347801 DOI:
10.1016/j.amsu.2021.102602]
[Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2021] [Revised: 07/15/2021] [Accepted: 07/25/2021] [Indexed: 11/19/2022] Open
Abstract
INTRODUCTION
Balo's Concentric Sclerosis (BCS) is a rare demyelinating disease sometimes considered a variant of multiple sclerosis. It is characterized by an acute or subacute neurological symptoms with characteristic MRI "onion-like" white matter lesions. BCS has a wide range of presentations but is mostly self-limiting. Steroids are indicated in patients with aggressive disease.
CASE PRESENTATION
We report 2 cases of BCS with monophasic course of stroke-like symptoms and single periventricular concentric lamella with onion-like appearance on MRI without inflammatory reaction in the CSF. They were treated with corticosteroids achieving clinical improvement and without neurological deficit or relapse over the following years.
CLINICAL DISCUSSION
A number of cases of BCS are described in the literature that show marked recovery with early diagnosis and treatment with steroids.
CONCLUSION
BCS appears to have a good prognosis when treated early in its diagnosis with steroids.
Collapse